SCINAI IMMUNOTHERAPEUTICS LTD. Cost of Revenue
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Cost of Revenue of $3.96 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-04-01
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|
| 2025-12-31 | $3.96M 20-F · filed 2026-04-01 | |
| 2025-06-30 | $2.04M 6-K · filed 2025-09-02 | |
| 2024-12-31 | $1.24M 20-F · filed 2026-04-01 | |
| 2024-06-30 | $448.00K 6-K · filed 2025-09-02 |